CSI Market
Sign In | Register

Boston Scientific (BSX) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access BSX quarterly Cash Flow →
Cash flow data covering Boston Scientific–Dec 31 2021 offers a view into how Dec 31 2025's cash position has developed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income2,892.00
Depreciation & amortization1,368.00
Amortization of Other Assets0.00
Impairment charges0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability64.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-188.00
Equity in loss of uncons. Affiliate0.00
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal0.00
Share-based Compensation299.00
Prepaid expenses0.00
Restructuring charge0.00
Cash Flow Impact Of Deferred Income Tax Expense Benefit-2.00
Purchased Research And Development-
Payment For Contingent Consideration Liability Operating Activities-
Contingent Consideration Expense-
Inventory Step Up Amortization132.00
Net Currency Exchange Gain Loss-
Goodwill And Intangible Asset Impairment-
Income taxes42.00
Gain (Loss) on Investments-139.00
Increase (Decrease) in Accounts Receivable-269.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities296.00
Investing losses/ -gains net0.00
Stock compensation0.00
Advance billings and deposits.0.00
Other Working Capital-85.00
Restricted stock compensation0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities124.00
Discontinued operations0.00
Net Cash flow from Operating Activities4,534.00
Investing Activities
Capital Expenditures-876.00
Sale of Capital Items0.00
Short-term investments liq.0.00
Short-term investments acq.0.00
Payments for (Proceeds from) Hedge, Investing Activities0.00
Proceeds From Divestiture Of Businesses Net Of Costs-
Proceeds From Sales Of Equity Securities And Collections Of Notes Receivable-
Purchases Of Privately Held Securities-
Proceeds From Payments For Investments And Acquisitions Of Certain Technologies-254.00
Purchases of other investments0.00
Noncontrolling interest0.00
Proceeds from Investments0.00
Payments for (Proceeds from) Other Investments0.00
Purchases of non-current assets0.00
Payments to Acquire Businesses, Net of Cash Acquired-1,593.00
Investment in affiliate0.00
Proceeds from Divestiture of Businesses0.00
Proceeds from sale of assets0.00
Payments for (Proceeds from) Loans Receivable, Total0.00
Payments for (Proceeds from) Other Investing Activities84.00
Other Net-1.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-2,640.00
Financing Activities
Short-term debt Net-1,791.00
Other borrowing transactions0.00
Long-term debt - borrowings1,558.00
Long-term debt - repayments0.00
Noncontrolling interest0.00
Issuances / -repurchases of Comm. Stock282.00
Exercise of stock options0.00
Issuances / -repurchases of Pref. Stock0.00
Discontinued Operations0.00
Other financing activities net0.00
Other net-919.00
Payment Of Contingent Consideration-
Paymenttonetsharesettleemployeeequityawards-131.00
Paymentofcontingentconsiderationinfinancing-
Cashcashequivalentsrestrictedcashandrestrictedcashequivalents Periodincreasedecrease-
Cashcashequivalentsrestrictedcashandrestrictedcashequivalents-
Business Acquisition Contingent Consideration Cash Payment-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents606.00
Payments For Royalty Rights-
Proceeds From Secured Borrowings Relating To Royalty Arrangements-
Finance Lease Principal Payments-
Dividends paid to minority interests0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-395.00
Effect of exchange rate on cash flow42.00
Discontinued operations0.00
Free Cash Flow3,658.00
Total Cash Flow1,541.00
4 historic quarters locked

Sign in to unlock the full Boston Scientific cash flow history.

Sign In Create Free Account

About Boston Scientific Corp Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 17, 2026
  • Source: bsx-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000885725-26-000010

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License